Ultrafast CT developer Imatron of South San Francisco, CA, saidlast week that it has completed a $16 million private equity placementfor its HeartScan Imaging subsidiary, which operates ultrafastCT-based imaging centers. The infusion will help Imatron
Ultrafast CT developer Imatron of South San Francisco, CA, said
last week that it has completed a $16 million private equity placement
for its HeartScan Imaging subsidiary, which operates ultrafast
CT-based imaging centers. The infusion will help Imatron establish
HeartScan as a separate business that will purchase Imatron scanners.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.